Literature DB >> 1771213

Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity.

T H Hand1, G J Marek, L S Seiden.   

Abstract

The behavioral effects of racemic mianserin, its (+) and (-) enantiomers, and its metabolites desmethylmianserin and 8-hydroxymianserin were evaluated on the differential-reinforcement-of-low-rate 72-s (DRL 72-s) schedule, a screen known to be sensitive to and specific for the antidepressant properties of drugs. Racemic mianserin produced the antidepressant-like effect (increased reinforcement rate, decreased response rate) at 5 and 10 mg/kg. The mianserin enantiomers showed the antidepressant-like effect beginning at lower doses [(+) mianserin; 0.6 mg/kg; (-) mianserin: 2.5 mg/kg]. The mianserin metabolites showed no clear dose-related effect at doses up to 10 mg/kg. It is concluded that the antidepressant-like effects of mianserin are due to the activity of the parent compound rather than to its metabolites, and that they may be primarily attributable to the (+) enantiomer. The greater potency of (+)-mianserin may be related to its higher affinity for the 5-HT2 receptor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1771213     DOI: 10.1007/bf02244363

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  40 in total

1.  Blockade of presynaptic alpha-receptors and of amine uptake in the rat brain by the antidepressant mianserine.

Authors:  P A Baumann; L Maître
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

2.  5HT2 binding sites after mianserin: comparison of loss of sites and brain levels of drug.

Authors:  E Sanders-Bush; M Breeding; M Roznoski
Journal:  Eur J Pharmacol       Date:  1987-01-13       Impact factor: 4.432

3.  Some effects of a new tetracyclic anti-depressant compound, Org GB 94, on the metabolism of monoamines in the rat brain.

Authors:  B E Leonard
Journal:  Psychopharmacologia       Date:  1974-04-23

4.  The effect of (+/-)mianserin and its enantiomers on the behavioural hyperactivity of the olfactory-bulbectomized rat.

Authors:  S M Jancsár; B E Leonard
Journal:  Neuropharmacology       Date:  1984-09       Impact factor: 5.250

5.  Selective inhibition of MAO-A, not MAO-B, results in antidepressant-like effects on DRL 72-s behavior.

Authors:  G J Marek; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  The central antiserotonergic action of mianserin.

Authors:  J Maj; H Sowińska; L Baran; L Gancarczyk; A Rawłów
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

7.  Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system.

Authors:  E Sanders-Bush; M Breeding; K Knoth; M Tsutsumi
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  The effects of serotonin antagonists in a behavioral despair procedure in mice.

Authors:  D Luttinger; M Freedman; L Hamel; S J Ward; M Perrone
Journal:  Eur J Pharmacol       Date:  1984-12-15       Impact factor: 4.432

9.  Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.

Authors:  G A Kennett; G Curzon
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

10.  Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness.

Authors:  K Ghose; A Coppen; P Turner
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

View more
  7 in total

1.  Antidepressant-like activity of EMD 386088, a 5-HT6 receptor partial agonist, following systemic acute and chronic administration to rats.

Authors:  Magdalena Jastrzębska-Więsek; Agata Siwek; Anna Partyka; Bernadeta Szewczyk; Magdalena Sowa-Kućma; Anna Wasik; Marcin Kołaczkowski; Anna Wesołowska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-06-16       Impact factor: 3.000

2.  Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer.

Authors:  S Cheeta; C Broekkamp; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

Review 3.  Chirality and drugs used in psychiatry: nice to know or need to know?

Authors:  R M Lane; G B Baker
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

4.  Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system.

Authors:  M K Nixon; M Hascoet; M Bourin; M C Colombel
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

Review 5.  Escitalopram versus citalopram: the surprising role of the R-enantiomer.

Authors:  Connie Sánchez; Klaus P Bøgesø; Bjarke Ebert; Elin Heldbo Reines; Claus Braestrup
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

6.  The enantioselective synthesis of (S)-(+)-mianserin and (S)-(+)-epinastine.

Authors:  Piotr Roszkowski; Jan K Maurin; Zbigniew Czarnocki
Journal:  Beilstein J Org Chem       Date:  2015-08-28       Impact factor: 2.883

7.  In Search of the Most Stable Molecular Configuration of Heptakis(2,6-O-dimethyl)-β-cyclodextrin and Its Complex with Mianserin: A Comparison of the B3LYP-GD2 and M062X-GD3 Results.

Authors:  Anna Ignaczak; Łukasz Orszański
Journal:  J Phys Chem B       Date:  2021-11-24       Impact factor: 2.991

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.